The Company is a Korea-based company engaged in the biotechnology area. The Company focuses on the research and development of deoxyribonucleic acid (DNA) chips, for which it made a distribution and technical contract with Affimatrix; stem cells, which proceeds radical cure of disease by transplanting new cell or tissue, and biopharmaceuticals technology. The Company was established on April 1, 1994. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on October 25, 2005.
Headquarters
4Th Floor A Dong Korea Bio Park 694-1 Sampyeong-Dong, Bundang-Gu, Seongnam-Si
Seongnam; Gyeonggi;
Postal Code: 134-030
Contact Details: Purchase the Seoulin Bio Science Co.,Ltd. report to view the information.
Website: http://www.seoulin.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service